Everything on Pharmaceuticals / AI

Novo Nordisk's collaboration with OpenAI shows a trend of integrating AI into core R&D to shorten drug discovery processes and increase hit rates.

Impact: AI integration in pharma could drastically reduce the time-to-market for new medications, creating a competitive advantage for early adopters.

— from Market Trends: Bank Earnings, AI Integration and Neo-Broker Evolution · Alles auf Aktien – Die täglichen Finanzen-News· Apr 15, 2026